Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Antonadou D, Paraskevaidis M, Sarris G et al. (2002) Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 20:3644–3650
Berardi R, Porfiri E, Scartozzi M et al. (2003) Elderly patients with advanced non-small cell lung cancer. A phase II study with weekly cisplatin and gemcitabine. Oncology 65(3):198–203
Blackstock AW, Hess S, Chaney S et al. (1999) Oxaliplatin: in vitro evidence of its radiation sensitizing activity. Preclinical observations relevant to clinical trials. Int J Radiat Oncol Biol Phys 45:253
Budach W, Paulsen F, Welz S et al. (2002) Mitomycin C in combination with radiotherapy as a potent inhibitor of tumour cell repopulation in a human squamous cell carcinoma. Br J Cancer 86:470–476
Carraro S, Roca EL, Cartelli C et al. (2002) Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study. Int J Radiat Oncol Biol Phys 54:397–402
Choy H, Kim DW (2003) Chemotherapy and irradiation interaction. Sem Oncol 30(Suppl 9):3–10
Cividalli A, Ceciarelli F, Livdi E et al. (2002) Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule. Int J Radiat Oncol Biol Phys 52:1092–1098
Corsa PA (2003) A preliminary retrospective study with temozolomide and radiotherapy versus radiotherapy alone for the treatment of high-grade glioma. Int J Radiat Oncol Biol Phys 57:S378
Davies Cde L, Lundstrom LM, Frengen J et al. (2004) Radiation improves distribution and uptake of liposomal doxorubicin (caelyx) in human osteosarcoma xenografts. Cancer Res 64:547–553
Douillard JY, Cunningham D, Roth AD et al. (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicenter randomised trial. Lancet 355:1041–1047
Dunst J, Reese T, Setter T et al. (2002) Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol 20:3983–3991
De Lange SM, van Groeningen CJ, Mejer OWM et al. (2002) Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer. Eur J Cancer 38:1212–1217
Epelbaum R, Rosenblatt E, Nasrallah S et al. (2002) Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer. J Surg Oncol 81:138–143
Feliu J, Calvillo J, Escribano A et al. (2002) Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy. Ann Oncol 13:730–736
Flam MS, John M, Pajak T et al. (1996) Role of mitomycin C in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14:2527–2539
Freyer G, Bossard N, Romestaing P et al. (2001) Addition of oxaliplatin to continuous fluorouracil, L-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R97-03 phase I trial. J Clin Oncol 19:2433–2438
Gerard JP, Chalet O, Nemoz C et al. (2003) Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial. J Clin Oncol 21:1119–1124
Giaccone G, Herbst RS, Manegold C et al. (2004) Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial — INTACT 1. J Clin Oncol 22:777–784
Glimelius B, Jakobsen A, Graf W et al. (1998) Bolus injection (2–4 min) versus short-term (10–20 min) infusion of 5-fluo-rouracil in patients with advanced colorectal cancer: a prospective randomised trial. Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Eur J Cancer 34:674–678
Glynne-Jones R, Sebag-Montefiore D, McDonald A et al. (2003) Phase I/II study of preoperative radiation and capecitabine in combination with oxaliplatin in locally advanced rectal cancer: the Socrates study. Proc Am Soc Clin Oncol 22:1174
Hartmann JT, Oechsle K, Quietzsch D et al. (2003) Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study. Br J Cancer 89:2051–2056
Heidelberger C, Chaudhuari NK, Danneberg P et al. (1957) Fluorinated pyrimidines: a new class of tumor inhibitory compounds. Nature 179:2557–2560
Heidelberger C, Griesbach L, Montag BJ et al. (1958) Studies on fluorinated pyrimidines II. Effects of transplanted tumors. Cancer Res 18:305–317
Herbst RS, O’Reilly MS (2003) The rationale and potential of combining novel biologic therapies with radiotherapy: focus on non-small cell lung cancer. Sem Oncol 30(Suppl 9):113–123
Herbst RS, Giaccone G, Schiller JH et al. (2004) Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial — INTACT 2. J Clin Oncol 22:785–794
Hirose Y, Berger, Pieper RO (2001) P53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Cancer Res 61:1957–1963
Hoff PM, Janjan N, Saad ED et al. (2000) Phase I study of pre-operative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer. J Clin Oncol 18:3529–3534
Hofheinz R, Hartmann J, Hartung G et al. (2003) Increasing doses of capecitabine in combination with mitomycin: a phase I study in patients with pretreated gastrointestinal cancer. Proc Am Soc Clin Oncol 22:1316
Hofheinz R, von Gerstenberg-Helldorf B, Wenz F et al. (2004) Phase-I-study of irinotecan (CPT-11) and capecitabine in combination with concurrent radiotherapy for locally advanced rectal cancer. Proc Am Soc Clin Oncol 23:2203
Jensen JN, Lock-Andersen J, Langer SW et al. (2003) Dexrazoxane — a promising antidote in the treatment of accidental extravasation of anthracyclines. Scand J Plast Reconstr Hand Surg 37:174–175
Khushalani NI, Leichman CG, Proulx G et al. (2002) Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer. J Clin Oncol 20:2844–2850
Klautke G, Kirchner R, Hopt U et al. (2001) Continuous infusion of 5-FU and weekly irinotecan with concurrent radiotherapy as neoadjuvant treatment for locally advanced or recurrent rectal cancer. Proc Am Soc Clin Oncol 20:555
Kretzschmar A, Pink D, Thuss-Patience P et al. (2003) Extravasations of oxaliplatin. J Clin Oncol 21:4068–4069
Kris MG, Natale RB, Herbst RS et al. (2003) Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small-cell lung cancer. A randomized trial. JAMA 290:2149–2158
Kuten A, Anacak Y, Abdah-Bortnyak R et al. (2003) Neoadjuvant radiotherapy concurrent with weekly paclitaxel and carboplatin and followed by surgery in locally advanced non-small-cell lung cancer. Am J Clin Oncol 26:184–187
Lanzetta G, Campanella C, Rozzi A et al. (2003) Temozolomide in radio-chemotherapy combination treatment for newly diagnosed glioblastoma multiforme: phase II clinical trial. Anticancer Res 23:5159–5164
Lövey J, Koronczay K, Remenár E et al. (2003) Radiotherapy and concurrent low-dose paclitaxel in locally advanced head and neck cancer. Radiother Oncol 68:171–174
Loibl S, von Minckwitz G, Schwedler K et al. (2003) Mitomycin, folinic acid, 5-FU (Mi-Fo-FU) as salvage chemotherapy for hepatic failure due to liver metastases in breast cancer. Proc Am Soc Clin Oncol 22:326
Mader I, Fürst-Weger PR, Mader RM (Hrsg) (2002) Paravasation von Zytostatika. Ein Kompendium für Prävention und Therapie. Springer, Berlin Heidelberg New York Tokio
Mason KA, Hunter NR, Milas M et al. (1997) Docetaxel enhances tumor radioresponse in vivo. Clin Cancer Res 3:2431–2438
Maurer AM, Masters GA, Haraf DJ et al. (1998) Phase I study of docetaxel with concomitant thoracic radiation therapy. J Clin Oncol 16:159–164
Mehta VK, Cho CC, Ford JM et al. (2003) Phase II trial of pre-operative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys 55:132–137
Meyer JL, Vaeth JM (Hrsg) (1992) Radiotherapy/chemotherapy interactions in cancer treatment. Karger
Molls M (1996) Prinzipien der Kombination von Radiotherapie und Chemotherapie. In: Scherer E, Sack H (Hrsg) Strahlentherapie. Radiologische Onkologie. Springer, Berlin Heidelberg New York Tokio, S 189–205
Mose S, Class R, Weber HW et al. (2002) Kombination von Radiotherapie und Gemcitabine. Bewertung klinischer Daten auf der Basis experimenteller Erkenntnisse. Strahlenther Onkol 178:59–70
Mudad R, Ramsey M, Kovitz K et al. (2003) Concomitant weekly docetaxel, cisplatin and radiation therapy in locally advanced non-small cell lung cancer: a dose finding study. Lung Cancer 39:173–177
O’Connell MJ, Martenson JA, Weiand HS et al. (1994) Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502–507
Rich TA, Kirichenko AV (2001) Camptothecin schedule and timing of administration with irradiation. Oncology 15(Suppl 5):37–41
Robert F, Ezekiel MP, Spencer SA et al. (2001) Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer. J Clin Oncol 19:3234–3243
Rödel C, Grabenbauer GG, Papadopoulos T et al. (2003) Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21:3098–3104
Rotman M, Aziz H, Wasserman TH (1997) Chemotherapy and irradiation. In: Perez CA, Brady LW et al. (eds) Principles and Practice of Radiation Oncology. Lippincott-Raven Publishers, pp 705–722
Saußele S, Petzold A, Gemünden C et al. (2003) DPD deficiency in patients treated with 5-fluorouracil and capecitabine detected by melting curve analysis. Onkologie 26(Suppl 5):793
Scagliotti GV, Manegold C, Buchholz E et al. (2002) Randomized phase II study evaluating the feasibility of thoracic radiotherapy with or without weekly docetaxel (taxotere) following induction chemotherapy with cisplatin and docetaxel in unresectable stage IIIA-B non-small cell lung cancer. Proc Am Soc Clin Oncol 21:1279
Schilsky RL (1992) Biochemical pharmacology of chemotherapeutic drugs used as radiation enhancers. Sem Oncol 19(Suppl ll):2–7
Steren A, Sevin BU, Perras J et al. (1993) Taxol sensitizes human ovarian cancer cells to radiation. Gyn Oncol 48:282–285
Stupp R, Dietrich PY, Kralijevic SO et al. (2002) Promising survival for patients with newly diagnosed glioblastoma multi-forme treated with concomitant radiation plus temozolomide. J Clin Oncol 20:1375–1382
Tempero M, Plunkett W, Ruiz Van Haperen V et al. (2003) Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma. J Clin Oncol 21:3402–3408
Tepper JE, O’Connell MJ, Petroni GR et al. (1997) Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114. J Clin Oncol 15:2030–2039
Tishler RB, Geard CR, Hall EJ et al. (1992) Taxol sensitizes astrocytoma cells to radiation. Cancer Res 52:3495–3497
Topaly J, Frühauf S, Ho AD et al. (2002) Rationale for combination therapy of chronic myelogeneous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning. Br J Cancer 86:1487–1493
Ulutin HC, Pak Y (2003) Preliminary results of radiotherapy with or without weekly paclitaxel in locally advanced non-small cell lung cancer. J Cancer Res Clin Oncol 129:52–56
van den Bent MJ, Taphoorn MJ, Brandes AA et al. (2003) Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. J Clin Oncol 21:2525–2528
van Rijn J, Heimans JJ, van den Berg J et al. (2000) Survival of human glioma cells treated with various combinations of temozolomide and x-rays. Int J Radiat Oncol Biol Phys 47:779–784
Wilkowski R, Thoma M, Heinemann V et al. (2003) Radiochemotherapie mit Gemcitabin und Cisplatin bei Pankreaskarzinom — durchführbar und effektiv. Strahlenther Onkol 179:78–86
Williams KJ, Telfer BA, Stratford IJ et al. (2001) Combination of ZD1839 (Iressa), an EGFR tyrosine kinase inhibitor, and radiotherapy increases antitumour efficacy in a human colon cancer xenograft model. Proc Am Ass Cancer Res 42:3840
Workman P (1992) Infusional anthracyclines: is slower better? If so, why? Ann Oncol 3:591
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hofheinz, R.D., Hochhaus, A. (2006). Kombination von Zytostatika mit Strahlentherapie: Radio-Chemo-Therapie. In: Wannenmacher, M., Debus, J., Wenz, F. (eds) Strahlentherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68520-3_11
Download citation
DOI: https://doi.org/10.1007/978-3-540-68520-3_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22812-7
Online ISBN: 978-3-540-68520-3
eBook Packages: Medicine (German Language)